|
|
||||||||


,1
* Department of Biochemistry/Biophysics, University of Pennsylvania, Philadelphia, Pennsylvania 19104;
Covance, Princeton, New Jersey 08540;
Children's Hospital of Philadelphia; Philadelphia, Pennsylvania 19104; and
Aventis, Bridgewater,NewJersey
| Abstract |
|---|
|
|
|---|
Key Words: diabetes heart mitochondria sodium calcium oxidative phosphorylation
| Introduction |
|---|
|
|
|---|
Na+-induced abnormalities in energetics have been demonstrated in diabetes mellitus (DM) heart and isolated cardiomyocytes (5, 7). The role of mitochondria in these changes is still unclear. In DM heart mitochondria, we and others have shown that parameters of respiration and oxidative phosphorylation are decreased when
-ketoglutarate (KG) or pyruvate (plus malate) are used as substrate (710). At present, it is unclear whether changes in bioenergetics contribute to altered Na+ transport, or whether altered Na+ transport leads to progressively depressed mitochondrial bioenergetic function (or both), possibly by inducing changes mitochondrial matrix Ca2+ levels.
Mitochondrial Ca2+ uptake capacity is significantly depressed in diabetic cardiomyocytes compared with control (11). Cox and Matlib (12) have shown that activation of the mitochondrial Na+-Ca2+ exchanger by extramitochondrial Na+ leads to Ca2+ efflux and subsequent decrease in matrix-free Ca2+. The role of mitochondrial Ca2+ is important in the regulation of several matrix dehydrogenases (DH; including pyruvate DH, isocitrate DH, and
-ketoglutarate DH) involved in oxidative ATP synthesis (1315). It is possible that the decrease of mitochondrial Ca2+ can result in decreased activity of these Ca2+-sensitive dehydrogenases, which can lead to a decrease in turnover of the Krebs cycle intermediates, resulting in a decreased rate of oxidative phosphorylation.
The goal of the work presented in this paper was to further evaluate the role of Na+i in regulation of mitochondrial respiration and oxidative phosphorylation in diabetic, in contrast to control, hearts. We found that Na+i does regulate mitochondrial ATP levels.
| Materials and Methods |
|---|
|
|
|---|
Polarographic Experiments.
Heart mitochondria preparation for polarographic studies.
For polarographic experiments, mitochondria were isolated from one or two male rat hearts using a method of differential centrifugation previously described (10). Briefly, hearts were quickly excised and chilled. Blood was washed from the heart through the aorta and pulmonary artery with cold buffer No. 1 containing (in millimoles): sucrose, 300; N-[2-hydroxyethyl]piperazine-N'-[2-ethanesulfonic acid] (HEPES), 10 (pH 7.4); ethylene glycol-bis(ß-aminoethyl ether)-2N,N,N',N'-tetraacetic acid) (EGTA), 5 or 10; and bovine serum albumin (BSA), 0.25% at a temperature of 0° to 4°C.
Hearts were initially homogenized in buffer No. 1 (8 ml of buffer per 1 g of tissue) with a Teflon pestle containing a metal core. The primary homogenate was homogenized again with a routine Glass/Teflon Potter-Elvehjem homogenator. Nuclei and other cellular debris were sedimented at 420 to 500g for 8 min. The supernatant was centrifuged at 8000g for 15 min. The mitochondria pellet was resuspended and re-centrifuged in buffer No. 2 containing (in millimoles): KCl, 180; HEPES, 10 (pH 7.4); and EGTA, 0.05 at a temperature of 0° to 4°C. Finally, the mitochondrial pellet was diluted in buffer No. 2 to a concentration of 6 to 7 mg of protein per 1 ml, and was kept in the tube on ice until polarographic measurements were made.
Measurement of oxygen consumption.
Mitochondria respiration and oxidative phosphorylation were studied with polarographic methods using a Clark oxygen electrode (YSI 5300 Biological Oxygen Monitor, YSI Inc., Yellow Springs, OH). State 3 (oxygen consumption stimulated by ADP), State 4 (oxygen consumption after cessation of ADP phosphorylation), respiratory control index (RCI; ratio State 3 and State 4), and rate of oxidative phosphorylation (ROP; State 3 x ADP/O) were measured. The incubation medium (buffer No. 3) for this procedure contained (in millimoles): KCl, 180; KHPO4, 1; and HEPES, 5 (pH 7.4). Because Cox and Matlib (12, 17) demonstrated that 0.2 to 1 mM
-ketoglutarate (but not 10 mM) was the optimal substrate concentration's range to reveal the Na+ effect on State 3 and NADH formation in heart mitochondria, we decided to use 1 mM
-ketoglutarate as oxidative substrate for our polarographic experiments. Different concentrations of NaCl (in millimoles: 1.0, 3.0, 5.0, and 10) were added to the polarographic cuvette (volume of 1.5 ml) to evaluate the effects of Na+ on mitochondrial function.
To check that mitochondrial function for NMR experiments was comparable with that of mitochondria used for routine polarography, mitochondrial respiratory function was determined prior to NMR studies using buffer No. 4 containing (in millimoles): sucrose, 250; KCl, 50; HEPES, 5 (pH 7.4); and ethylenediaminetetraacetic acid (EDTA), 0.5.
For polarography experiments, the concentration of mitochondria in the cuvette was 1.13 ± 0.04 mg of protein. In some experiments, 1 µM Ruthenium Red (RR), a blocker of mitochondrial Ca2+ uptake, or 250 µM diltiazem (DLTZ), a blocker of Na+/Ca2+ exchange, was added to the cuvette before the addition of NaCl. In another set of experiments to evaluate the effect of Ca2+on the Na+ effect, two different concentrations of Ca2+ (0.035 and 0.114 µM) were added to the cuvette before the addition of NaCl. In another set of experiments to evaluate the pH dependence of Na+ effect, buffer No. 3 with different pHs (adjusted with KOH and/or HCl to 6.7, 7.0, 7.2, and 7.4) were used.
NMR Experiments.
Heart mitochondria preparation for NMR studies.
Mitochondria were isolated from four hearts for each experiment. The mitochondria isolation techniques for NMR studies were similar to those described above for polarographic studies with the following differences. After final centrifugation, three-fourths of the mitochondria pellet was suspended in 0.8 ml of buffer No. 5 containing (in millimoles): sucrose, 150; KCl, 50; KH2PO4, 1; HEPES, 20 or 30; MgSO4, 2; EDTA, 0.5; creatine, 2.5; KG, 5; ADP, 0.6; and ATP, 2. The remainder (approximately one-fourth) of the mitochondria pellet was suspended in buffer No. 2 (0.2 ml) for polarographic measurement of mitochondrial function. After completion of polarographic measurements, all isolated mitochondria not used in polarography were combined with the other mitochondria and were embedded in agarose beads.
Incorporation of mitochondria into agarose beads for NMR experiments.
To maintain mitochondria in a stable environment during NMR experiments, they were placed in agarose beads using methods previously described (18, 19). In brief, the mitochondria suspension was added to 1.5 ml of gelling agarose (6%; Sigma type VII: low gelling temperature of 70°C) in buffer No. 5 (37°C) and stirred. The mitochondria/agarose suspension was immediately added to 50 ml of mineral oil (37°C) and was stirred continuously with a magnetic stirrer for 5 min, while decreasing the water bath temperature to 10°C. The interaction of the oil and agarose caused the formation of the beads with the following characteristics: bead size
800 to 1000 µm; 2000 to 2500 beads/cm3; 6 to 7 mg of mitochondrial protein per 1 ml; and the average volume of mitochondria in the beads was 84 to 120 µl (18). The oil was removed and beads were rewashed with 200 ml of buffer No. 5, now containing 0.25% BSA.
Perfusion apparatus for NMR experiments.
Beads containing mitochondria were placed in a 10-mm diameter glass NMR tube and maintained in place by a filter (100-µm pore size) (17) and continuously superfused at 2.7 ml/min (28°C). The superfusion medium (buffer No. 3 without ATP and BSA) was gassed with 95% O2/5% CO2.
31P-NMR.
The NMR measurements were performed on a Bruker AM-400 spectrometer (Billerica, MA) at 162 MHz using 60o pulses and a 0.62-sec repetition time with 1000 accumulations over 10 min (18, 19).
Protein Measurement.
Mitochondrial protein was measured prior to polarography with the Bio-Rad Protein Assay (Bio-Rad Assay, Hercules, CA) method (rapid determination of protein) to estimate the amount of protein to add to the polarography cuvette (
1 mg of protein/cuvette). To accurately measure mitochondrial protein used for each set of polarographic studies, mitochondrial protein was measured with the Lowry method (19) after each polarographic experiment. Rates of respiration and oxidative phosphorylation were calculated per 1 mg of protein (Lowry method).
To determine protein for each NMR experiment, mitochondria in agarose beads were homogenized in 10 ml of 0.1 N NaOH, and protein concentration was measured with the Lowry method.
Statistical Analysis.
The parameters of mitochondrial respiration and high-energy phosphate content were analyzed by two-way analysis of variance (ANOVA). Then, post hoc comparisons among the experimental groups were performed using least significant difference (LSD) tests. All values are reported as means ± SEM.
| Results |
|---|
|
|
|---|
|
|
Na+ effects on mitochondrial function in diabetic heart compared with control: overall ANOVA analysis.
The overall two-way ANOVA showed a significant disease (diabetic) effect with respect to State 3, State 4, ROP, ADP/O ratio, and RCI (Table II
). The ANOVA also showed a significant sodium effect with respect to State 3, State 4, ROP, but not with respect to ADP/O ratio and RCI. The results of post hoc comparisons for CON and DM groups are presented following text.
|
RR alone did not change mitochondria respiratory function. For example, State 3 (in nanograms of atoms of oxygen per minute per milligram of protein) without RR was 184.5 ± 16.6; and with RR it was 184.8 ± 16.9. However, when RR was used in conjunction with Na+, Na+ caused larger depression in mitochondria respiratory function (State 3) in both CON and DM (Fig. 2
). For example, in CON mitochondria, the decrease of State 3 after addition 10 mM Na+ without RR was -32.3% (P < 0.05) and with RR it was -42.1% (P < 0.01). In DM, this effect was -43.3% (P < 0.05) and -61.1% (P < 0.01), respectively (Fig. 2
). It appears the RR influence on the Na+ effect is greater in DM than in CON.
|
|
|
|
|
|
| Discussion |
|---|
|
|
|---|
Other studies in animal models of DM reveal that myocardial dysfunction is associated with depressed cardiomyocyte bioenergetics, as evidenced by changes in mitochondrial function (State 3, ROP, and ATP levels) (710, 28).
The goal of the present group of studies was to show that increased Na+i is a cause of depressed mitochondrial bioenergetics. Our first set of experiments, done with mitochondria from CON rats, was designed to simulate the increased intracellular Na+ found in the diabetic condition (5, 29). In this case, exposure of heart mitochondria from control rats to increasing levels of Na+ caused decreases in State 3 and ROP; thus suggesting that changes in cellular Na+ levels can be involved in depression of bioenergetic function in cardiomyopathies such as those associated with DM.
To further evaluate the Na+ effect in a DM model, we also exposed DM mitochondria to varying levels of Na+. We found that DM mitochondria were much more sensitive to extramitochondrial Na+ levels than CON, suggesting that the DM condition (and long-term exposure to increased Na+i) causes residual changes (possibly with upregulation and/or downregulation of various mitochondrial membrane and transport systems) in mitochondrial function. We went on to further explore the potential etiology of these effects.
Since we knew from the literature and from some our earlier studies that Na+ and Ca2+ transport (and their potential effects on metabolism) are intimately related (17, 29), we completed a number of experiments to evaluate the potential role of intramitochondrial Ca2+ on the Na+ effects in both CON and DM mitochondria. We found that when Ca2+ uptake was blocked by RR, the Na+ (10 mM) depressant effect on bioenergetics was increased in both CON and DM, but that in DM mitochondria, the effect of RR was significantly greater. These data suggest that baseline Ca2+ is lower in DM than CON. Further support of this hypothesis was found when the addition of Ca2+ to the mitochondrial cuvette caused an amelioration of the Na+ depressant effects on State 3 and ROP. Of note, higher concentrations of Ca2+ were needed to reverse the effects of Na+ in DM compared with CON.
These results are consistent with those of others, which show that in DM the energy-dependent intramitochondrial Ca2+ uptake is inhibited, resulting in decreased intramitochondrial Ca2+ (8, 11, 26). Ca2+ regulation of bioenergetic functions can be realized in the physiological range of Ca2+ (0.11 µM). In our experiments, the absence of a clear saturation effect of Na+-induced decrease of State 3 could be explained by a decrease of mitochondrial Ca2+ to a range lower than that found in physiological conditions, which in turn could lead to depletion of bioenergetic processes and nonreversible decrease of membrane potential and ATP synthesis.
The level of intramitochondrial Ca2+ is also under control of the mitochondrial Na+-Ca2+ exchanger, which mediates the efflux of Ca2+ in exchange for the influx of Na+ (30, 31). It is possible that the increase Na+i in diabetic cardiomyocytes leads to activation of the Na+-Ca2+ exchanger, which mediates mitochondrial Ca2+ release from mitochondria (13, 22, 23). DLTZ, an inhibitor of the Na+-Ca2+ exchanger, abolished the Na+ effect on bioenergetics in CON and DM, further confirming the intimate relationship of Na+ and Ca2+ on bioenergetics.
With depletion of intramitochondrial Ca2+, bioenergetic functions (State 3, ROP, and substrate oxidation) have been found to be significantly reduced (710, 28). These abnormalities could be the result of altered dehydrogenase activity; e.g., Ca2+-dependent DH such as
-ketoglutarate DH, pyruvate DH, or isocitrate DH could be depressed due to decrease in Ca2+. The decrease of enzyme activity can lead to a decrease in turnover of the Krebs cycle intermediates, resulting in a decreased rate of oxidative phosphorylation. The decrease of the Ca2+-dependent Krebs cycle DH activity could also lead to an increased NAD+/NADH ratio, thus decreasing electron flow through the mitochondrial respiratory chain, and decreasing the electrochemical proton gradient on the mitochondrial membrane. These changes subsequently could lead to decreased ATP synthesis. Our 31P NMR data support this hypothesis; i.e., exposure of mitochondria to increasing levels of exogenous Na+ was associated with decrease of ATP levels. These decreases were significantly greater in DM mitochondria compared with CON. The energetic deficit may be a causal factor in the development of contractile dysfunction and may be linked to the lower levels of Ca2+ in mitochondria from DM rats.
Because the Na+ effect may be related to H+ levels and may be at least partially dependent on Na+-H+ exchanger activity, in one set of experiments we exposed mitochondria to different H+ levels (by changing pH) to evaluate the interaction of Na+ with H+ ions. We found in both DM and CON that external buffer pH 7.4 (the plasma pH that is generally considered to be the most physiologic) allowed the largest Na+ effect. Higher pHs did not significantly change the Na+ depressant effect, while lower pHs (7.2, 7.0, and 6.7) decreased the Na+ depressant effect on State 3 and ROP. However, DM mitochondria were less sensitive to changes in external buffer pH, as demonstrated by persistence of Na+ effects down to pH 7.0. This may be due to the fact that intracellular pH is generally lower in DM compared with CON cardiomyocytes due to downregulation of the Na+-H+ exchanger (32). The pH effect may be related to a number of physiological processes, including pH dependence of the mitochondrial Na+-Ca2+ exchanger and the Na+-H+ exchanger. In addition, the pH effect may be related to the opening of the permeability transition pore (PTP). The mitochondrial permeability transition can be caused by a loss of Ca2+ (for example, due to Na+-induced activation of the Na+-Ca2+ exchanger), and an entry of protons, giving rise to a greater decrease of the transmembrane potential and
pH (33). The maximum opening probability is observed at pH close to 7.3 (34, 35). It is interesting that our data show that the maximum effect of Na+ depression on State 3 was found at pH 7.27 ± 0.02 (Table II
), a pH close to the maximum opening probability for the PTP. At pH 7.0 and lower, the opening of the PTP is inhibited (34). This may explain why the Na+ inhibitory effect on State 3 does not occur at lower pHs (7.0 and 6.7).
In summary, altered bioenergetics found in DM cardiomyopathy may be associated with Na+ and Ca2+ abnormalities: both higher baseline cytoplasmic Na+i and lower mitochondrial Ca2+ may contribute to altered bioenergetics found in the cardiomyopathic myocytes. The effects of Na+ on bioenergetics may be mediated through effects on Ca2+; i.e., due to activation of mitochondrial Na+-Ca2+ exchange by Na+, and energy-dependent decreased Ca2+ uptake, leading to decreased mitochondrial matrix Ca2+, which in turn prevents optimum activity of mitochondrial Ca2+-dependent dehydrogenases. It is possible that the changes (increased Na+ and decrease Ca2+) found in DM mitochondria may act similar to the ischemic preconditioning effects found in isolated perfused control hearts, in that they may allow DM hearts to withstand ischemia better than non-preconditioned control hearts (36).
Our data suggest that while localized changes in bioenergetic function may be a cause of ion transport abnormalities, it is just as likely that abnormalities of cytoplasmic ion content and mitochondrial ion transport mechanisms may contribute to metabolic (bioenergetic and respiratory function) abnormalities. Results of the present study suggest that increased Na+ concentration in diseased cardiomyocytes may be a factor leading to chronically decreased myocardial bioenergetics and to development of diabetic cardiomyopathy.
| Footnotes |
|---|
1 To whom requests for reprints should be addressed at Biochemistry/Biophysics Department, 207 Anatomy/Chemistry Building, University of Pennsylvania, 37th Street and Hamilton Walk, Philadelphia, PA 19104. E-mail: mary.osbakken{at}aventis.com ![]()
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
T. Liu and B. O'Rourke Enhancing Mitochondrial Ca2+ Uptake in Myocytes From Failing Hearts Restores Energy Supply and Demand Matching Circ. Res., August 1, 2008; 103(3): 279 - 288. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zungu, M. P. Alcolea, F. J. Garcia-Palmer, M. E. Young, and M. F. Essop Genomic modulation of mitochondrial respiratory genes in the hypertrophied heart reflects adaptive changes in mitochondrial and contractile function Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H2819 - H2825. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Babsky, S. Hekmatyar, S. Wehrli, N. Doliba, M. Osbakken, and N. Bansal Influence of Ischemic Preconditioning on Intracellular Sodium, pH, and Cellular Energy Status in Isolated Perfused Heart Experimental Biology and Medicine, July 1, 2002; 227(7): 520 - 528. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |